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Abstract Parry-Romberg syndrome (PRS) is a rare con-
dition manifesting with progressive hemifacial atrophy.
Although reported PRS clinical disturbances include facial
pain and recent studies raised the possibility that
PRS-related pain is a neuropathic pain condition due to the
trigeminal nerve damage, no studies have directly investi-
gated cutaneous innervation and trigeminal pathway func-
tion in patients with this rare condition. In a 50-year-old
woman presenting with a 10-year history of slowly pro-
gressive hemifacial atrophy and facial pain, we investi-
gated large myelinated fibres with masticatory muscle
electromyography and trigeminal reflexes, and tested small
myelinated and unmyelinated fibres with laser-evoked
potentials. We also investigated cutaneous innervation by
measuring the intraepidermal nerve fibre (IENF) density
after skin biopsy of the supraorbital regions. We found that
neurophysiological data and IENF density came within
normal ranges, with no differences between normal and
affected side. Our study showing that the standard refer-
ence techniques for assessing cutaneous innervation and
trigeminal pathway function disclosed no abnormalities in
this patient with PRS suggest that this rare and disabling
condition is not associated with trigeminal system damage.
These findings indicate that in this patient PRS-related pain
is not a neuropathic pain condition, rather it probably arises
from the musculoskeletal abnormalities.
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Introduction
Parry-Romberg syndrome (PRS) is a rare condition mani-
festing with progressive hemifacial atrophy involving skin,
soft tissue, and bone. Reported PRS clinical disturbances
include facial pain [1, 2]. The documented inflammatory
changes in the brain parenchyma and vessel walls, occa-
sional coexisting autoimmune disorders and clinical
improvement following immunosuppression suggest that
PRS could be an immune-mediated disease [3]. Despite
recent studies suggesting that PRS-related pain is a neu-
ropathic pain condition due to trigeminal nerve damage, no
studies have directly investigated cutaneous innervation
and trigeminal pathway function in patients with this rare
condition. Having this information might help to under-
stand the underlying causes of PRS, thus opening the way
to a therapeutic approach.
Case presentation
A 50-year-old woman presented with a 10-year history of
slowly progressive hemifacial atrophy associated with facial
pain. Her medical history was unremarkable except for high
blood pressure. Clinical examination showed facial asym-
metry with marked hypoplasia involving the right face, and
right enophthalmos. The patient complained of a dull, aching
pain affecting the right face. Pain was continuous, deeply and
poorly localised, mainly distributed to the supra- and peri-
orbital regions, temple, ear, and zygomatic area. Pain was
mild in intensity, with no significant variations during the day.
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The remaining clinical and neurological examinations were
normal, including a detailed sensory examination using bed-
side tools. The soft brush and the pinprick stimulation of the
skin did not evoke pains (namely dynamic mechanical allo-
dynia and hyperalgesia). We assessed large myelinated fibres
with masticatory muscle electromyography and trigeminal
reflexes (blink reflex and masseter inhibitory reflex) [4], and
tested small myelinated and unmyelinated fibres (Ad- and
C-fibres) with laser-evoked potentials [5]. We also investi-
gated cutaneous innervation by measuring the intraepidermal
nerve fibre (IENF) density after skin biopsy of the supraorbital
regions. The methods used adhered to European Guidelines
[6], and published recommendations [7, 8]. The blink reflex
was evoked by electrical stimulation of the supraorbital nerve.
EMG signals were recorded from the orbicularis oculi through
surface electrodes. The masseter inhibitory reflex was evoked
by electrical stimulation of the infraorbital and mental nerves,
while the subjects were instructed to clench the teeth at
maximum strength with the aid of auditory feedback. EMG
signals were recorded from the masseter muscle through
surface electrodes. To study laser-evoked potentials we used a
previously reported technique [9]. The main Ad- and C-LEP
complex, N2–P2, was recorded through disc electrodes from
the vertex (Cz) referenced to the nose. We measured peak
latency and amplitude (peak-to-peak) of the main N2–P2
vertex complex.
For sampling skin innervated by the trigeminal nerve,
after local anaesthesia 2-mm punch biopsies were taken
above the eyebrow. Samples were processed for bright-
field immunohistochemistry, using antibodies against
protein gene product (PGP) 9.5, as a marker for intraepi-
dermal nerve fibres. Neurophysiological and IENF data
were compared with normative ranges established in our
laboratory.
Laboratory testing showed no abnormalities. Investiga-
tion for rheumatic disease, including rheumatoid factor, anti-
dsDNA antibody, extractable nuclear antigen screening were
normal. Computerised tomographic (CT) and magnetic
resonance imaging (MRI) scans showed severe hemiatrophy
involving facial subcutaneous tissues and facial bones, but
no brain lesions. Neurophysiological data and IENF density
came within normal ranges, with no differences between
normal and affected side (Figs. 1, 2).
Discussion
Our study showing that the standard reference techniques
for assessing cutaneous innervation and trigeminal pathway
function disclosed no abnormalities in a patient with PRS
and facial pain suggest that in our patient this rare and
disabling condition is not associated with trigeminal sys-
tem damage. This implies that in this patient affected by
PRS, the facial pain is not a neuropathic pain condition.
The recent criteria for diagnosing neuropathic pain assume
that a definite diagnosis of neuropathic pain requires con-
firmatory evidence from neurologic examination and lab-
oratory investigation showing the damage of the
somatosensory afferent pathway [10].
Previous studies raised the possibility that PRS-related
pain is a neuropathic pain condition [1, 2]. In these studies
the diagnosis of neuropathic pain relied on clinical exam-
ination and quantitative sensory testing (QST) abnormali-
ties showing hyperalgesia and allodynia [2]. Although QST
abnormalities are also found in non-neurological diseases
and they cannot be taken as a conclusive demonstration of
neuropathic pain [11, 12], and these studies did not perform
an objective assessment of trigeminal afferent pathway, we
cannot exclude that our patient presented with a different
phenotype. Indeed the patient reported by Viana and col-
leagues also suffered from a severe, shooting pain resem-
bling trigeminal neuropathic pain.
According to our data we hypothesise that in our patient
PRS-related pain is a nociceptive pain condition that might
arise from the musculoskeletal abnormalities. These abnor-
malities might be directly due to the immune-mediated
damage of soft tissues and bone or a consequence of the
Fig. 1 Skin biopsy from the normal and affected supraorbital region.
Intraepidermal nerve fibres (IENF) immunostained with the panax-
onal marker anti-protein gene product 9.5 in a 50-lm skin section.
Arrows indicate normal IENF crossing the dermo-epidermal junction.
Scale bar 50 lm. The IENF density was 13.1/mm at the normal
supraorbital region and 15.1/mm at the affected supraorbital region
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musculoskeletal impairment affecting temporomandibular
joint and masticatory muscles.
Further studies assessing trigeminal pathway function
are needed to verify whether PRS-related pain is invariably
a nociceptive pain condition or different type of pain
(namely neuropathic pain) may occur.
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Fig. 2 Neurophysiological
testing after stimulation of the
normal and affected side. Blink
reflex (a) after supraorbital
nerve stimulation and masseter
inhibitory reflex (b) after
infraorbital nerve stimulation.
Three trials superimposed.
Calibration 10 ms/200 lV for a,
20 ms/200 lV for b.
Ad- (c) and C-fibres (d) related
laser-evoked potentials after
supraorbital stimulation. Two
averages of ten trials each
superimposed. Calibration
200 ms/20 lV. The latency and
the amplitude of short
(R1 and SP1) and long latency
(R2 and SP2) trigeminal reflex
responses, and vertex
components (N2 and P2) of
laser-evoked potentials were
within normal ranges, with no
side asymmetry
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